Credit: Shutterstock photoIf you're looking for stocks that are setting up in a base ahead of their next earnings report, here's one that fits the bill: IBD 50 and Sector Leaders member Lam Research ( LRCX ). It's expected to report on Jan. 23 and is currently about 10% below a 219.80 entry. The base is a fourth-stage consolidation .
[ibd-display-video id=2360792 width=50 float=left autostart=true] Understand that buying a stock just ahead of earnings involves risk since you typically don't have enough time to establish a profit cushion before the latest quarterly numbers come out. Be sure to follow sound buy and sell rules to minimize your exposure.
See How IBD Helps You Make More Money In Stocks
The company showed 91% earnings growth last quarter. Sales gains came in at 52%.
Consensus analyst estimates call for earnings-per-share growth of 64% for the quarter, and 46% growth for the full year. Annual growth estimates were recently revised lower.
Lam Research has a 97 Composite Rating and holds the No. 1 rank among its peers in the Electronics-Semiconductor Equipment industry group. Entegris ( ENTG ) and Lam Research ( LRCX ) are also among the group's highest-rated stocks.
Note: Dates for earnings reports are subject to change. Check the company's website for any updates.
RELATED:
Earnings Calendar, Analyst Estimates And Stocks To Watch
New Option Strategy Limits Risk Around Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
